Remedi Lists on Korea's Kosdaq on July 13 at 20,700 Won Per Share
According to Yonhapnews, portable X-ray device manufacturer Remedi debuted on South Korea's Kosdaq market on July 13 at 20,700 won per share, marking its successful listing after two previous failed attempts. The public offering recorded a competition ratio of 1,706:1.
Separately, H.L.G Genomics, a
GateNews·07-11 00:19
